相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
C. Louwrens Braal et al.
DRUGS (2021)
LNCcation: lncRNA localization and function
Mary Catherine Bridges et al.
JOURNAL OF CELL BIOLOGY (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling
Shipeng Zheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer
Xinxing Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
BCLAF1 promotes cell proliferation, invasion and drug-resistance though targeting lncRNA NEAT1 in hepatocellular carcinoma
Shao-Jiao Mou et al.
LIFE SCIENCES (2020)
被撤回的出版物: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation (Retracted article. See vol. 21, 2022)
Mingli Han et al.
MOLECULAR CANCER (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Long Noncoding RNA in Myeloid and Lymphoid Cell Differentiation, Polarization and Function
Imran Ahmad et al.
CELLS (2020)
Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer
Ruinian Zheng et al.
AGING-US (2020)
LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
Yang Li et al.
CANCER CELL INTERNATIONAL (2020)
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer
Tingting Ma et al.
CELLULAR SIGNALLING (2020)
Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells
Lei Yan et al.
ENVIRONMENTAL TOXICOLOGY (2020)
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway
Zhaolin Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Long non-coding RNA AK085865 ablation confers susceptibility to viral myocarditis by regulating macrophage polarization
Yingying Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER plus breast cancer
Xi Jin et al.
MOLECULAR CANCER (2020)
Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis
Rongfeng Qu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis
Chunhong Liu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1
Li Tang et al.
FRONTIERS IN ONCOLOGY (2020)
Structure of LINC00511-siRNA-conjugated nanobubbles and improvement of cisplatin sensitivity on triple negative breast cancer
Bolin Wu et al.
FASEB JOURNAL (2020)
lncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells
Alfredo Garcia-Venzor et al.
CARCINOGENESIS (2020)
LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1
Ming Zhang et al.
CELL PROLIFERATION (2020)
Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/CDK2 axis promotes progression of ER plus breast cancer and confers tamoxifen resistance
Jing Feng et al.
AGING-US (2020)
lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy
Mingli Han et al.
MOLECULAR THERAPY (2020)
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
Xiaorong Lin et al.
CELL REPORTS (2020)
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
Michela Piezzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
LncRNA-SNHG7 Enhances Chemotherapy Resistance and Cell Viability of Breast Cancer Cells by Regulating miR-186
Hui Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
Wei Ma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
Qiongyu Hao et al.
CELL DEATH & DISEASE (2020)
LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
Zhi-hua Li et al.
FRONTIERS IN ONCOLOGY (2020)
Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
Shuai Yuan et al.
FRONTIERS IN ONCOLOGY (2020)
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer
Qianfeng Shi et al.
NATURE COMMUNICATIONS (2020)
Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature
Jianguo Lai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells
Mingzhi Zhu et al.
CELL CYCLE (2020)
LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis
Chuang Du et al.
CELL TRANSPLANTATION (2020)
miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer
Yue Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO
Jinghua Chen et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2020)
Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells
Chao Ni et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
LncRNAs regulate metabolism in cancer
Wenyu Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1
Yu Wang et al.
BIOENGINEERED (2020)
被撤回的出版物: Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway (Retracted article. See vol. 237, pg. 2004, 2022)
Peng-Wei Lu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer
Yun Ma et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Apoptosis: A mammalian cell bioprocessing perspective
Antonio L. Grilo et al.
BIOTECHNOLOGY ADVANCES (2019)
ER upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-B in breast cancer
Zhanwei Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Transcriptome analysis of luminal breast cancer reveals a role for LOL in tumor progression and tamoxifen resistance
Wei Sun et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/-catenin signaling pathway by regulating WNT2
Dian-Hui Xiu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
Vivian Yvonne Shin et al.
CELL DEATH & DISEASE (2019)
Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity
Zhongqiu Zheng et al.
MEDICAL SCIENCE MONITOR (2019)
LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years
Chit Tam et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Cell death: a review of the major forms of apoptosis, necrosis and autophagy
Mark S. D'Arcy
CELL BIOLOGY INTERNATIONAL (2019)
Phospho-RNA-seq: a modified small RNA-seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma
Maria D. Giraldez et al.
EMBO JOURNAL (2019)
LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway
Xianfu Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer
Shouping Xu et al.
MOLECULAR CANCER (2019)
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
Fei Chen et al.
NATURE CELL BIOLOGY (2019)
LncRNA Profile Study Reveals a Three-LncRNA Signature Associated With the Pathological Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer
Ying Zeng et al.
FRONTIERS IN PHARMACOLOGY (2019)
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Zewu Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression
Jingjing Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19
Pengfei Zheng et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2019)
PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway
Xue Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
Ji Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis
Hualong Zhang et al.
LIFE SCIENCES (2019)
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Qingsong Hu et al.
NATURE IMMUNOLOGY (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
ESR1-Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression
Yuichi Mitobe et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis
Na Yao et al.
ONCOGENE (2019)
Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors
Orsolya Galamb et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Functional impact of the long non-coding RNA MEG3 deletion by CRISPR/Cas9 in the human triple negative metastatic Hs578T cancer cell line
Carlos Deocesano-Pereira et al.
ONCOLOGY LETTERS (2019)
Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis
Xiaoqiong Luo et al.
CANCER CELL INTERNATIONAL (2019)
Long non-coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway
Zhuo Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAAT/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p
Lei Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer
Huaying Dong et al.
MOLECULAR CANCER (2019)
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
Alex J. Gooding et al.
ONCOGENE (2019)
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway
Ze-Yu Sun et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches
Xingyang Qian et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGAI/miR-218 Axis
Jingyu Wang et al.
ONCOTARGETS AND THERAPY (2019)
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Elena Martin-Orozco et al.
FRONTIERS IN IMMUNOLOGY (2019)
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1
Junmei Cairns et al.
BREAST CANCER RESEARCH (2019)
LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2
Zhenghua Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Silencing lnc-ASAH2B-2 Inhibits Breast Cancer Cell Growth via the mTOR Pathway
Jingjing Li et al.
ANTICANCER RESEARCH (2018)
Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1
Hua-yu Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway
Xiulei Zhang et al.
BIOCHEMISTRY-MOSCOW (2018)
Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer
Yiran Liang et al.
CANCER BIOLOGY & THERAPY (2018)
Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer
Juan Gu et al.
CANCER LETTERS (2018)
LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation
Xuanxuan Wang et al.
CELL CYCLE (2018)
Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer
Liang Chang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
被撤回的出版物: Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer (Retracted article. See vol. 62, 2023)
Wei Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
被撤回的出版物: Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer (Retracted article. See vol. 61, 2022)
Huaying Dong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1
Ruoming Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Breast cancer diagnosis: Imaging techniques and biochemical markers
Seyed Hamed Jafari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
Yangang Ma et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells
Mohammad Javad Dehghan Esmatabadi et al.
PHYTOMEDICINE (2018)
A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer
Yiran Liang et al.
CELL DEATH & DISEASE (2018)
Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a
Yanqin Sun et al.
CELL DEATH & DISEASE (2018)
Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
Yiyuan Pan et al.
CELL AND BIOSCIENCE (2018)
Immune Modulation by Human Secreted RNases at the Extracellular Space
Lu Lu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Platforms for Investigating LncRNA Functions
John Lalith Charles Richard et al.
SLAS TECHNOLOGY (2018)
被撤回的出版物: Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation (Retracted article. See vol. 42, 2023)
Huaying Dong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
被撤回的出版物: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA (Retracted article. See vol. 42, 2023)
Min Kang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
被撤回的出版物: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88 (Retracted article. See vol. 42, 2023)
Huaying Dong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death
Di Huang et al.
NATURE IMMUNOLOGY (2018)
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant Check triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
Chin-Chuan Chen et al.
CANCERS (2018)
Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process
Hongli Gao et al.
ONCOTARGETS AND THERAPY (2018)
The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
Hao Wang et al.
CELL DEATH & DISEASE (2018)
DSCAM-AS1 regulates the G1/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy
Wei Sun et al.
CANCER MEDICINE (2018)
Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1
Jia Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells
Pratima Basak et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer
Xuerui Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Regulation of Human Breast Cancer by the Long Non-Coding RNA H19
Jordan Collette et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Blocking the Cycle: Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic, Hormone Receptor-Positive Breast Cancer
Seth A. Wander et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cell Cycle Control by PTEN
Andrew Brandmaier et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
Wan-xin Peng et al.
MOLECULAR CANCER (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
LncRNA-mediated regulation of cell signaling in cancer
W-X Peng et al.
ONCOGENE (2017)
Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer
Yuehua Li et al.
TUMOR BIOLOGY (2017)
LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway
Qiong-Ni Zhu et al.
ONCOTARGET (2017)
Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer
Kecheng Zhang et al.
THERANOSTICS (2017)
How do lncRNAs regulate transcription?
Yicheng Long et al.
SCIENCE ADVANCES (2017)
Long Noncoding RNAs as Biomarkers in Cancer
Luka Bolha et al.
DISEASE MARKERS (2017)
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis
Gloria Ravegnini et al.
AUTOPHAGY (2017)
LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway
Peng Du et al.
BIOSCIENCE REPORTS (2017)
Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer
Zuguo Yuan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
Hong-Yan Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Molecular mechanisms of drug resistance and its reversal in cancer
Melis Kartal-Yandim et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)
Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss
Gayatri Arun et al.
GENES & DEVELOPMENT (2016)
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
X. Xue et al.
ONCOGENE (2016)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
Jia-Hui Xu et al.
CANCER CELL INTERNATIONAL (2016)
PTEN regulates PLK1 and controls chromosomal stability during cell division
Zhong Zhang et al.
CELL CYCLE (2016)
Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
Ting Shi et al.
DISEASE MARKERS (2016)
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li et al.
DRUG RESISTANCE UPDATES (2016)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
Circulating long non-coding RNAs in cancer: current status and future perspectives
Peng Qi et al.
MOLECULAR CANCER (2016)
Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes
Janine H. van Ree et al.
NATURE CELL BIOLOGY (2016)
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
Xiunan Li et al.
TUMOR BIOLOGY (2016)
Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells
Yao-Min Chen et al.
TUMOR BIOLOGY (2016)
PTEN regulates EG5 to control spindle architecture and chromosome congression during mitosis
Jinxue He et al.
Nature Communications (2016)
Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer
Wentong Li et al.
ONCOTARGET (2016)
LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK
Xinxin Si et al.
ONCOTARGET (2016)
Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
Chihua Wu et al.
MEDICAL SCIENCE MONITOR (2016)
RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity
Evangelos Pefanis et al.
CELL (2015)
PTEN regulates RPA1 and protects DNA replication forks
Guangxi Wang et al.
CELL RESEARCH (2015)
Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon
Zacharenia Nikitaki et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Epithelial-mesenchymal transition and drug resistance in breast cancer
Jing Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
PTEN regulates DNA replication progression and stalled fork recovery
Jinxue He et al.
NATURE COMMUNICATIONS (2015)
LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
Sheng-Jia Shi et al.
ONCOTARGET (2015)
PTEN Controls the DNA Replication Process through MCM2 in Response to Replicative Stress
Jiawen Feng et al.
CELL REPORTS (2015)
Elevated expression of long intergenic non-coding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells
Yan Zhuang et al.
MOLECULAR CARCINOGENESIS (2015)
An update on PARP inhibitors-moving to the adjuvant setting
Amir Sonnenblick et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
A novel long non-coding RNA-ARA: Adriamycin Resistance Associated
Min Jiang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Qiong Wu et al.
CANCER LETTERS (2014)
SnapShot: Histone Modifications
He Huang et al.
CELL (2014)
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Mirjam C. Boelens et al.
CELL (2014)
Therapeutic Targeting of Cancers with Loss of PTEN Function
Lloye M. Dillon et al.
CURRENT DRUG TARGETS (2014)
Biomarkers in prostate cancer: what's new?
David A. Sartori et al.
CURRENT OPINION IN ONCOLOGY (2014)
Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: A meta-analysis
Wu-Jin Xue et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
Diagnostic value of urine prostate cancer antigen 3 test using a cutoff value of 35 μg/L in patients with prostate cancer
Bin Hu et al.
TUMOR BIOLOGY (2014)
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
JulieAnn Rader et al.
CLINICAL CANCER RESEARCH (2013)
Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis
Haikuo Tang et al.
MOLECULAR MEDICINE REPORTS (2013)
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
C. Bassi et al.
SCIENCE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Genome Regulation by Long Noncoding RNAs
John L. Rinn et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
Genome-wide analysis of long noncoding RNA stability
Michael B. Clark et al.
GENOME RESEARCH (2012)
Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer
Anniina Koski et al.
MOLECULAR THERAPY (2012)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
Breast cancer - one term, many entities?
Nicholas R. Bertos et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
M. F. E. Godinho et al.
BRITISH JOURNAL OF CANCER (2010)
Non-coding RNAs: regulators of disease
Ryan J. Taft et al.
JOURNAL OF PATHOLOGY (2010)
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
David J. McConkey et al.
CANCER AND METASTASIS REVIEWS (2009)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
GASTROENTEROLOGY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Michael Dean
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Regulation of estrogenic effects by Beclin 1 in breast cancer cells
Shali John et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
Vera Levina et al.
PLOS ONE (2008)
Why is PTEN an important tumor suppressor?
Li Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action
Rahul Palchaudhuri et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and snail
Hyun-Jung Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Essential role for nuclear PTEN in maintaining chromosomal integrity
Wen Hong Shen et al.
CELL (2007)
Self-eating and self-killing: crosstalk between autophagy and apoptosis
M. Chiara Maiuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail
Stefan Grotegut et al.
EMBO JOURNAL (2006)
Wnt-dependent regulation of the E-cadherin repressor snail
JI Yook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation
LA Timmerman et al.
GENES & DEVELOPMENT (2004)
Autophagy in health and disease: A double-edged sword
T Shintani et al.
SCIENCE (2004)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)